Strategies to Improve Patient Outcomes and QOL: Current Complications of the Design and Placements of Ureteric Stents

Overview

Journal Res Rep Urol

Publisher Dove Medical Press

Specialty Urology

Date 2020 Aug 18

PMID 32802807

Citations 10

Authors

Meghana Ramachandra

Ali Mosayyebi

Dario Carugo

Bhaskar K Somani

Affiliations

Soon will be listed here.

Abstract

Ureteric stents have played a vital role in relieving urinary obstruction in many urological conditions. Although they are extremely successful, stents have been associated with complications and reduced patients' health-related quality of life (HRQoL). There are many factors that may affect the quality and longevity of stents. In this review, we have highlighted the journey and innovation of ureteric stents through the modern day. A literature review was conducted to identify relevant articles over the last 20 years. There is a plethora of evidence with various indications for the use of ureteral stents and how they affect QoL. There is still ongoing research to develop the ideal stent with reduced encrustation, one that resists infection and is also comfortable for the patients. Stents made from metal alloys, polymers and biodegradable materials have unique properties in their own right but also have certain deficiencies. These have been discussed along with an overview of newly developed stents. Certain pharmacological adjuncts have also been highlighted that may be useful to improve patient's tolerance to stents. In summary, this paper describes the features of the different types of stents and the problems that are frequently encountered, including effect on patients' HRQoL and financial burden to healthcare providers.

Citing Articles

Antegrade stenting for chronic malignant ureteral obstruction with the Resonance metallic stent: a case series.

Teo D, Hoe J, So W, Ho C, Ong S, Tiong H Int Urol Nephrol. 2024; 57(4):1077-1081.

PMID: 39541077 DOI: 10.1007/s11255-024-04286-0.

Prevention of complications in endourological management of stones: What are the basic measures needed before, during, and after interventions?.

Edison E, Mazzon G, Arumuham V, Choong S Asian J Urol. 2024; 11(2):180-190.

PMID: 38680580 PMC: 11053336. DOI: 10.1016/j.ajur.2023.04.003.

Evaluation of renovated double J stents using ureter models with and without stenosis.

Choi Y, Kang H, Kim K, Jo M, Islam M, Kim J World J Urol. 2024; 42(1):228.

PMID: 38598022 DOI: 10.1007/s00345-024-04920-7.

[Effects of delayed ureteral stents removal during the COVID-19 pandemic on the quality of life and psychological status of postoperative patients with urinary calculi].

Lai J, Wang Q, Ji J, Wang M, Tang X, Xu K Beijing Da Xue Xue Bao Yi Xue Ban. 2023; 55(5):857-864.

PMID: 37807740 PMC: 10560900.

Comparison of the Removal Efficiency and Safety of Magnetic Versus Conventional Ureteral Stents: A Systematic Review and Meta-analysis.

Cheng C, Ma Y, Jin S, Wen J, Jin X Eur Urol Open Sci. 2023; 52:22-29.

PMID: 37182117 PMC: 10172693. DOI: 10.1016/j.euros.2023.04.004.

References

Acosta-Miranda A, Milner J, Turk T . The FECal Double-J: a simplified approach in the management of encrusted and retained ureteral stents. J Endourol. 2009; 23(3):409-15. DOI: 10.1089/end.2008.0214. View

Hafron J, Ost M, Tan B, Fogarty J, Hoenig D, Lee B . Novel dual-lumen ureteral stents provide better ureteral flow than single ureteral stent in ex vivo porcine kidney model of extrinsic ureteral obstruction. Urology. 2006; 68(4):911-5. DOI: 10.1016/j.urology.2006.05.025. View

Minardi D, Cirioni O, Ghiselli R, Silvestri C, Mocchegiani F, Gabrielli E . Efficacy of tigecycline and rifampin alone and in combination against Enterococcus faecalis biofilm infection in a rat model of ureteral stent. J Surg Res. 2011; 176(1):1-6. DOI: 10.1016/j.jss.2011.05.002. View

Mosayyebi A, Yue Q, Somani B, Zhang X, Manes C, Carugo D . Particle Accumulation in Ureteral Stents Is Governed by Fluid Dynamics: In Vitro Study Using a "Stent-on-Chip" Model. J Endourol. 2018; 32(7):639-646. DOI: 10.1089/end.2017.0946. View

El-Nahas A, Lachine M, Elsawy E, Mosbah A, El-Kappany H . A randomized controlled trial comparing antimicrobial (silver sulfadiazine)-coated ureteral stents with non-coated stents. Scand J Urol. 2017; 52(1):76-80. DOI: 10.1080/21681805.2017.1376353. View

Lim W, Chen K, Chong T, Xiong G, Birch W, Pan J . A bilayer swellable drug-eluting ureteric stent: Localized drug delivery to treat urothelial diseases. Biomaterials. 2018; 165:25-38. DOI: 10.1016/j.biomaterials.2018.02.035. View

Wang C, Huang S, Chang C . Effects of specific alpha-1A/1D blocker on lower urinary tract symptoms due to double-J stent: a prospectively randomized study. Urol Res. 2009; 37(3):147-52. DOI: 10.1007/s00240-009-0182-8. View

Cauda F, Cauda V, Fiori C, Onida B, Garrone E . Heparin coating on ureteral Double J stents prevents encrustations: an in vivo case study. J Endourol. 2008; 22(3):465-72. DOI: 10.1089/end.2007.0218. View

Mosayyebi A, Vijayakumar A, Yue Q, Bres-Niewada E, Manes C, Carugo D . Engineering solutions to ureteral stents: material, coating and design. Cent European J Urol. 2017; 70(3):270-274. PMC: 5656375. DOI: 10.5173/ceju.2017.1520. View

10.

Liatsikos E, Karnabatidis D, Kagadis G, Rokkas K, Constantinides C, Christeas N . Application of paclitaxel-eluting metal mesh stents within the pig ureter: an experimental study. Eur Urol. 2006; 51(1):217-23. DOI: 10.1016/j.eururo.2006.05.054. View

11.

Candela J, Bellman G . Ureteral stents: impact of diameter and composition on patient symptoms. J Endourol. 1997; 11(1):45-7. DOI: 10.1089/end.1997.11.45. View

12.

Chew B, Rebullar K, Harriman D, McDougall E, Paterson R, Lange D . Percuflex Helical Ureteral Stents Significantly Reduce Patient Analgesic Requirements Compared to Control Stents. J Endourol. 2017; 31(12):1321-1325. DOI: 10.1089/end.2017.0349. View

13.

Kehinde E, Rotimi V, Al-Awadi K, Abdul-Halim H, Boland F, Al-Hunayan A . Factors predisposing to urinary tract infection after J ureteral stent insertion. J Urol. 2002; 167(3):1334-7. View

14.

Rukin N, Siddiqui Z, Chedgy E, Somani B . Trends in Upper Tract Stone Disease in England: Evidence from the Hospital Episodes Statistics Database. Urol Int. 2016; 98(4):391-396. DOI: 10.1159/000449510. View

15.

VanderBrink B, Rastinehad A, Ost M, Smith A . Encrusted urinary stents: evaluation and endourologic management. J Endourol. 2008; 22(5):905-12. DOI: 10.1089/end.2006.0382. View

16.

Lee Y, Huang K, Yang H, Chang H, Chen J, Yang T . Solifenacin improves double-J stent-related symptoms in both genders following uncomplicated ureteroscopic lithotripsy. Urolithiasis. 2013; 41(3):247-52. DOI: 10.1007/s00240-013-0554-y. View

17.

Ragab M, Soliman M, Tawfik A, Abdel Raheem A, El-Tatawy H, Abo Farha M . The role of pregabalin in relieving ureteral stent-related symptoms: a randomized controlled clinical trial. Int Urol Nephrol. 2017; 49(6):961-966. DOI: 10.1007/s11255-017-1561-7. View

18.

Song H, Park H, Suh T, Ko G, Kim T, Kim E . Recurrent traumatic urethral strictures near the external sphincter: treatment with a covered, retrievable, expandable nitinol stent--initial results. Radiology. 2003; 226(2):433-40. DOI: 10.1148/radiol.2262012160. View

19.

Ho C, Chen S, Chung S, Lee Y, Chen J, Yu H . Determining the appropriate length of a double-pigtail ureteral stent by both stent configurations and related symptoms. J Endourol. 2008; 22(7):1427-31. DOI: 10.1089/end.2008.0037. View

20.

Joshi H, Newns N, Stainthorpe A, MacDonagh R, Keeley Jr F, Timoney A . Ureteral stent symptom questionnaire: development and validation of a multidimensional quality of life measure. J Urol. 2003; 169(3):1060-4. DOI: 10.1097/01.ju.0000049198.53424.1d. View